Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 2601 - 2610 of 2615 results

First page
Previous page
261
Next page
Next page

CAPSICUM

00UK7646FG

Status:

US Approved Allergenic Extract (1974)

Source:

BLA102223

(1974)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=addbb916-198c-4992-98c3-a66b19a1e241

First marketed in 1921

Source:

Capsicum U.S.P.

Source URL:

https://www.gutenberg.org/files/41778/41778-h/41778-h.htm

Class:

STRUCTURALLY DIVERSE

EXEM FOAM KIT

WLT3PF2KX0

Status:

US Approved Rx (2019)

Source:

NDA212279

(2019)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212279

First approved in 2019

Source:

NDA212279

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212279

Class:

G1 SPECIFIED SUBSTANCE

RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN

COB9FF6I46

Status:

US Approved Rx (2017)

Source:

BLA125614

(2017)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2017

Source:

BLA125614

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN

25DB599G64

Status:

US Approved Rx (2014)

Source:

BLA125549

(2014)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2014

Source:

BLA125549

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN

1S25R442RS

Status:

US Approved Rx (2014)

Source:

BLA125549

(2014)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2014

Source:

BLA125549

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN

28E911Y7AE

Status:

US Approved Rx (2015)

Source:

BLA125546

(2015)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2014

Source:

BLA125549

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN

91523M4S24

Status:

US Approved Rx (2015)

Source:

BLA125546

(2015)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2014

Source:

BLA125549

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

BELIMUMAB

73B0K5S26A

Status:

US Approved Rx (2011)

Source:

BLA125370

(2011)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125370

First approved in 2011

Source:

BLA125370

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125370

Class:

CONCEPT

IBRITUMOMAB TIUXETAN

4Q52C550XK

Status:

US Approved Rx (2002)

Source:

BLA125019

(2002)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125019

First approved in 2002

Source:

BLA125019

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125019

Class:

CONCEPT

BORDETELLA PERTUSSIS PERTACTIN ANTIGEN

63GD90PP8X

Status:

US Approved Rx (2008)

Source:

BLA125145

(2008)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2002

Source:

BLA103666

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06f34d0f-4e72-41d3-967f-8abf3f2005c1

Class:

CONCEPT

Structurally Diverse

CAPSICUM

Concept

Concept

RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN

Concept

NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN

Concept

NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN

Concept

NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN

Concept

NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN

Concept

BELIMUMAB

Concept

IBRITUMOMAB TIUXETAN

Concept

BORDETELLA PERTUSSIS PERTACTIN ANTIGEN

Showing 2601 - 2610 of 2615 results

First page
Previous page
261
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1